Drug data last refreshed 15h ago · AI intelligence enriched 1w ago
Lithium carbonate is an oral small-molecule salt used primarily in the treatment of bipolar disorder, particularly for acute mania and maintenance therapy. It is one of the oldest psychiatric medications, with a narrow therapeutic window requiring careful monitoring of serum levels and renal/thyroid function. The mechanism involves modulation of neurotransmitter activity and intracellular signaling pathways, though the exact neurobiological basis remains incompletely understood.
With LOE approaching and intense generic competition (60/100 competitive pressure), the brand team is likely consolidating and focused on managed care contracting rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects
Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects
Worked on LITHIUM CARBONATE at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on lithium carbonate offers limited career upside in traditional commercial roles due to mature generic market status and LOE-approaching lifecycle. Opportunities instead concentrate in evidence generation, managed care contracting, and medical affairs—roles that emphasize relationship management and value demonstration over market expansion.